Log in

Start free trial
Home 5 Lab Industry Advisor 5 Laboratory Industry Report 5 Capital-lir 5 Theranos & Its CEO Settle Stock Fraud Charges with SEC

Theranos & Its CEO Settle Stock Fraud Charges with SEC

by | Apr 4, 2018 | Capital-lir, Industry Buzz-lir, Inside the Lab Industry-lir, Laboratory Industry Report, Top of the News-lir

Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a beleaguered group surrounded by legal adversaries and struggling to survive. Recent months have seen the firm retrench and seek to settle its […]

Seven years ago, Theranos was a $9 billion dynamo seemingly on the precipice of blowing the blood testing market wide open. Today, the company and its CEO and founder, Elizabeth Holmes, are a beleaguered group surrounded by legal adversaries and struggling to survive. Recent months have seen the firm retrench and seek to settle its…

This content is for Paid Members only.
Login Register